Boston (1)

Atypical Teratoid Rhabdoid Tumor (1)

Chordoma (1)

Epithelioid Sarcoma (1)

INI1 (SMARCB1)-Deficient Primary CNS Malignant Tumors (1)

Malignant Rhabdoid Tumor (MRT) (1)

Rhabdoid Tumor of the Kidney (RTK) (1)

SMARCA4-deficient Primary CNS Malignant Tumors (1)

Recruiting (1)

phase 1/phase 2 (1)

Susan Chi, MD (1)

Bristol-Myers Squibb (1)

Epizyme, Inc. (1)

ipilimumab (1)

nivolumab (1)

tazemetostat (1)

drug (1)

Other (1)

Interventional (1)

malignant rhabdoid tumor (mrt)

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recruiting

Jan 23, 2023